Immucell (ICCC) Other Working Capital Changes (2015 - 2025)
Immucell's (ICCC) quarterly Other Working Capital Changes came in at -$130536.0 in Q4 2025, down 244.6% on a YoY basis from $90274.0 in Q4 2024, and down 210.96% quarter-over-quarter from $117643.0 in Q3 2025.
Analysis
Immucell (ICCC) Other Working Capital Changes (2015 - 2025) Analysis & Trends
Immucell (ICCC) has reported Other Working Capital Changes for 16 consecutive years, with -$130536.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes fell 244.6% year-over-year to -$130536.0; the trailing twelve-month figure through Dec 2025 stood at $50911.0 (up 154.67% YoY), and the FY2025 full-year result was $50911.0, up 154.67% from the prior year.
- Other Working Capital Changes eased to -$130536.0 in Q4 2025 per ICCC's latest filing, from $117643.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $52061.0 in Q4 2022 and bottomed at -$12418.0 in Q3 2023.
- Historically, Other Working Capital Changes has averaged $1524.8 across 5 years, with a median of $151.5 in 2021.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes jumped 233.09% in 2023, then plunged 244.6% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$195298.0 in 2021, then increased by 8.01% to -$179662.0 in 2022, then jumped by 36.89% to -$113381.0 in 2023, then soared by 179.62% to $90274.0 in 2024, then slumped by 244.6% to -$130536.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$130536.0, $117643.0, and -$151911.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.47 Bn | 40.27 Bn | 779.09 Mn |
| 2 | Zoetis | 30.35 Bn | 28.67 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.56 Bn | 11.03 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.48 Bn | 1.40 Bn | 134.40 Mn |
| 5 | Immucell | 90.65 Mn | 81.79 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.71 Mn | 69.61 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 8,202.00 |
| Jun 30, 2025 | 8,202.00 |
| Mar 31, 2025 | 12,049.00 |
| Mar 31, 2025 | 12,049.00 |
| Dec 31, 2024 | 4,469.00 |
| Dec 31, 2024 | 4,469.00 |
| Sep 30, 2024 | -8,780.00 |
| Sep 30, 2024 | -8,780.00 |
| Jun 30, 2024 | -8,569.00 |
| Jun 30, 2024 | -8,569.00 |
| Mar 31, 2024 | -11,407.00 |
| Mar 31, 2024 | -11,407.00 |
| Dec 31, 2023 | -12,386.00 |
| Dec 31, 2023 | -12,386.00 |
| Sep 30, 2023 | -12,418.00 |
| Sep 30, 2023 | -12,418.00 |
| Jun 30, 2023 | -5,322.00 |
| Jun 30, 2023 | -5,322.00 |
| Mar 31, 2023 | 11,153.00 |
| Mar 31, 2023 | 11,153.00 |